Validation and Recalibration of PCE, China-PAR, and PREVENT Models for Estimating ASCVD Risk in China
In this Chinese cohort, the original PCE and China-PAR overestimated 10-year ASCVD risk, whereas PREVENT underestimated it. Recalibration mitigated such misestimation in the local population, potentially enhancing risk stratification in primary cardiovascular prevention in China.
Authors
- Aqian Wang (ORCID: https://orcid.org/0000-0001-7700-6505)
- Xue Tian (ORCID: https://orcid.org/0000-0001-6140-4162)
- Shouling Wu
- Haibin Li
- Ruolin Zhang
Institutions
- Harvard University (US)
- North China University of Science and Technology (CN)
- Capital Medical University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- Kailuan General Hospital (CN)
- Beijing Institute of Neurosurgery (CN)
- Beijing Chaoyang Emergency Medical Center (CN)
Publication Details
- Journal
- JACC Asia
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.jacasi.2025.12.015
- Primary Topic
- Cardiac Imaging and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00